Top Markets
Coin of the day
Gan & Lee Pharmaceuticals. Gan & Lee Pharmaceuticals.

Gan & Lee Pharmaceuticals.

603087
Rank in Stocks #3185
Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused... Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused on the discovery, development, manufacturing, and marketing of insulin analogues within the Chinese market. Their diverse product portfolio encompasses injectable therapies such as Basalin (an insulin glargine), Prandilin (an insulin lispro), Prandilin 25 (another insulin lispro variant), Raplin (an insulin aspart), Raplin 30 (an insulin aspart 30 formulation), and Similin 30 (an insulin injection). Beyond diabetes treatments, the company also offers various medical devices. Established in 1998, Gan & Lee Pharmaceuticals maintains its corporate headquarters in Beijing, People's Republic of China. The organization underwent a name change in April 2005, transitioning from its former identity as Beijing Gan & Lee Biotechnology Co., Ltd.
Share Price
$10.35
Market Cap
$6.19B
Change (1 day)
3.79%
Change (1 year)
4.34%
Country
CN
Trade Gan & Lee Pharmaceuticals. (603087)

Category

Stock price history for Gan & Lee Pharmaceuticals. (603087)
Highest end of day price: $10.41 on 2026-08-01

Lowest end of day price: $9.67 on 2020-06-01
Stock price history of Gan & Lee Pharmaceuticals. from 2020 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 0.64%
2025 49.04%
2024 -17.59%
2023 56.66%
2022 -56.78%
2021 -39.34%
2020 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$371.13 -21.75%
US
$188.78 -39.02%
FR
$161.64 23.75%
JP
$189.94 24.49%
US
$76.37 -5.96%
CH